The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: A reappraisal

Leukemia and Lymphoma

Volumn 54, Issue 11, 2013, Pages 2377-2384

  Baliakas, Panagiotis ^a   Kanellis, George ^b   Stavroyianni, Niki ^a   Fameli, Maria ^b   Anagnostopoulos, Achilles ^a   Stamatopoulos, Kostas ^a,c   Papadaki, Theodora ^b  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

Author keywords

Autoimmunity; Bone marrow biopsy; Chronic lymphocytic leukemia; CLL; Immunohistochemistry

Indexed keywords

BONE MARROW BIOPSY; CANCER INFILTRATION; CHRONIC LYMPHATIC LEUKEMIA; CYTOPATHOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; PRIORITY JOURNAL; REVIEW;

BIOPSY; BONE MARROW; BONE MARROW EXAMINATION; HEMATOPOIESIS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTES, TUMOR-INFILTRATING;

EID: 84885663178     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.780653     Document Type: Review

References (69)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engi J Med 2005;352:804-815.
2. Messmer BY, Messmer D, Allen SL, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005;115:755-764.
3. Burger TA, Ghia P, Rosenwald A, et al. The microenvironment in mature B-Cell malignancies: A target for new treatment strategies. Blood 2009;114:3367-3375.
4. Ghia P, Chiorazzi N, Stamatopoulos K. Microenvironmental influences in chronic lymphocytic leukaemia: The role of antigen stimulation. J Intern Med 2008;264:549-562.
5. Fais F, Ghiotto F, Hashimoto 5, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515-1525.
6. AgathangelidisA, DarzentasN, HadzidimitriouA, etal. Stereo typed B-Cell receptors in one third of chronic lymphocytic leukemia: Towards a molecular classification with implications for targeted therapeutic interventions. Blood 2012;119:4467-4475.
7. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
8. Hamblin YJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
9. Messmer BY, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004;200:519-525.
10. Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007; 109:259-270
11. Darzentas N, Hadzidimitriou A, Murray F, et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: Molecular and computational evidence. Leukemia 2010;24:125-132.
12. Chiorazzi N. Implications of new prognostic markers in chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2012:76-87.
13. Mertens D, Bullinger L, Stilgenbauer S. Chronic lymphocytic leukemia-genomics lead the way. Haematologica 2011;96:1402-1405.
14. Hillmen P. Using the biology of chronic lymphocytic leukemia to choose treatment. Hematology Am Soc Hematol Educ Program 20 11:104-109.
15. Montillo M, Hamblin T, Hallek M, et al. Chronic lymphocytic leukemia: Novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 2005;90:391-399.
16. Skowronska A, Parker A, Ahmed G, et al. Biallelic AYM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial. J Clin Oncol 2012;30:4524-4532.
17. Puente XS, Pinyol M, QuesadaV, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011;475:101-105.
18. Fabbri G, Rasi 5, Rossi D, et al. Analysis of the chronic lymphocytic leukemia coding genome: Role ofNOTCH1 mutational activation. J Exp Med 2011;208:1389-1401.
19. Quesada v, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2011;44:47-52.
20. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011;365:2497-2506.
21. Rossi D, Fangazio M, Rasi 5, et al. Disruption of BIRC3 associates with fludarabine chemorefractoriness in YP53 wild-type chronic lymphocytic leukemia. Blood 2012;1 19:2854-2862.
22. Oscier DG, Rose-Zerilli MT, Winkelmann N, et al. The clinical significance ofNOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood 2013;121:468-475.
23. Gunnarsson R, Mansouri L, Rosenquist R. Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies. Leuk Lymphoma 2013 Feb 28.
24. Damm F, Nguyen-Khac F, Fontenay M, et al. Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies. Leukemia 2012;26:2027-2031.
25. Furman BR. Prognostic markers and stratification of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 20 10:77-8 1.
26. Dohner H, Stilgenbauer 5, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343:1910-1916.
27. Zenz T, Mertens D, Dohner H, et al. Importance of genetics in chronic lymphocytic leukemia. Blood Rev 2011;25:131-137.
28. Klein U, Lia M, Crespo M, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 2010;17:28-40.
29. Lia M, Carette A, Tang H, et al. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood 2012;119:2981-2990.
30. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia up dating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446-5456.
31. Muller-Hermelink H, Montserrat E, Catovsky D, et al. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Swerdlow S, Campo E, Harris N, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp 180-182.
32. Shanafelt TD, Ghia P, Lanasa MC, et al. Monoclonal B-Cell lymphocytosis (MBL): Biology, natural history and clinical management. Leukemia 2010;24:512-520.
33. Ghia P, Caligaris-Cappio E Monoclonal B-Cell lymphocytosis: Right track or red herring? Blood 2012;119:4358-4362.
34. Charron D, Dighiero G, Raphael M, et al. Bone-marrow patterns and clinical staging in chronic lymphocyte leukaemia. Lancet 1977;2:819.
35. Rozman C, Montserrat E, Rodriguez-Fernandez JM, et al. Bone marrow histologic pattern-the best single prognostic parameter in chronic lymphocytic leukemia: A multivariate survival analysis of 329 cases. Blood 1984;64:642-648.
36. Mauro FR, De Rossi G, Burgio VL, et al. Prognostic value of bone marrow histology in chronic lymphocytic leukemia. A study of 335 untreated cases from a single institution. Haematologica 1994;79: 334-341.
37. Schade U, Bock 0, Vornhusen S, et al. Bone marrow infiltration pattern in B-Cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70). Hum Pathol 2006;37:1153-1161.
38. Hernandez-Nieto L, Montserrat-Costa E, Muncunill J, et al. Bone-marrow patterns and clinical staging in chronic lymphocytic leukaemia. Lancet 1977;1:1269.
39. Pangalis GA, Roussou PA, Kittas C, et al. Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non-Hodgkin?s lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis. Cancer 1984;54:702-708.
40. Viswanatha DS, Montgomery KD, Foucar K. Mature B-Cell neoplasms: Chronic lymphocytic leukemia-small lymphocytic lymphoma, B-Cell prolymphocytic leukemia, and lymphoplasmacytic lymphoma. In: Jaffe ES, Harris NL, Vardiman JW, et al., editors. Hematopathology. St. Louis, MO: Elsevier; 2011. pp.221-236.
41. Foucar K. B-Cell chronic lymphocytic leukemia and prolymphocytic leukemia. In: Knowles D, editor. Neooplastic hematopathology. Philadelphia: Lippincott Williams & Wilkins; 2001. pp 1505-1529.
42. Oscier DG, Matutes E, Copplestone A, et al. Atypical lymphocyte morphology: An adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol 1997;98:934-939.
43. Frater JL, McCarron KF, Hammel JP, et al. Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. Am J Clin Pathol 2001;116:655-664.
44. Ho AK, Hill 5, Preobrazhensky SN, et al. Small B-Cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias. Am J Clin Pathol 2009;131:27-32.
45. Bennett MH, Farrer-Brown G, Henry K, et al. Classification of non-Hodgkin?s lymphomas. Lancet 1974;304:405-408.
46. Yin CC, Lin P, Carney DA, et al. Chronic lymphocytic leukemia! small lymphocytic lymphoma associated with 1gM paraprotein. Am Clin Pathol 2005; 123:594-602.
47. Muller-Hermelink H, Catovsky D, Montserrat E, et al. Mature B-Cell neoplasms: Chronic lymphocytic leukaemia!small lymphocytic lymphoma. In: Jaffe E, Harris NL, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. pp 127-130.
48. Lennert K, Tamm I, Wacker HH. Histopathology and immunocytochemistry of lymph node biopsies in chronic lymphocytic leukemia and immunocytoma. Leuk Lymphoma 1991;5(Supplj:157-160.
49. Offit K, Louie DC, Parsa NZ, et al. Del (7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood 1995;86:2365-2370.
50. [SOj Athanasiadou A, Stamatopoulos K, Tsompanakou A, et al. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis. Cancer Genet Cytogenet 2006;168:109-119.
51. Criel A, Verhoef G, Vlietinck R, et al. Further characterization of morphologically defined typical and atypical CLL: A clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. Br J Haematol 1997;97:383-391.
52. Hjalmar V, Kimby E, Matutes E, et al. Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemic B-Cell disorders. Haematologica 1998;83:602-609.
53. Matutes E, Oscier D, Garcia-Marco L et al. Trisomy 12 defines a group of CLL with atypical morphology: Correlation between cytogenetic, clinical and laboratory features in 544 patients. Br Haematol 1996;92:382-388.
54. Schlette E, Medeiros U, Keating M, et al. CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype. Arch Pathol Lab Med 2003;127:561-566.
55. Evans HL, Polski JM, Deshpande V, et al. CD5 + true SLL!CLL with plasmacytic differentiation and an unusual lp36 translocation: Case report and review of the literature. Leuk Lymphoma 2000;39: 625-632.
56. Giles FJ, O?Brien SM, Keating MJ. Chronic lymphocytic leukemia in (Richter?s) transformation. Semin Oncol 1998;25:117-125.
57. Rossi D, Gaidano G. Richter syndrome: Molecular insights and clinical perspectives. Hematol Oncol 2009;27:1-10.
58. Williams J, Schned A, Cotelingam JD, et al. Chronic lymphocytic leukemia with coexistent Hodgkin?s disease. Implications for the origin of the Reed-Sternberg cell. Am J Surg Pathol 1991;15:33-42.
59. Momose H, Jaffe ES, Shin SS, et al. Chronic lymphocytic leukemia! small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin?s disease. Mediation by Epstein-Barr virus. AmJ Surg Pathol 1992;16:859-867.
60. Ohno T, Smir BN, Weisenburger DD, et al. Origin of the Hodgkin! Reed-Sternberg cells in chronic lymphocytic leukemia with Hodgkin?s transformation? Blood 1998;91:1757-1761.
61. Kanzler H, Kuppers R, Helmes 5, et al. Hodgkin and ReedSternberg-like cells in B-Cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: Potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin?s disease. Blood 2000;95:1023-1031.
62. Diehl LF, Ketchum LH. Autoimmune disease and chronic lymphocytic leukemia: Autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 1998;25: 80-97.
63. Pittaluga 5, Verhoef G, Maes A, et al. Bone marrow trephines. Findings in patients with hairy cell leukaemia before and after treatment. Histopathology 1994;25:129-135.
64. Henry K. Bone marrow dysplasia in patients at presentation (lymphoma related dyshaematopoiesis). 6th International Course on Bone Marrow Biopsy Pathology. Hannover: European Bone Marrow Working Group; 2003.
65. Berkowitz LR, Ross DW, Orringer EP. Hairy cell leukemia with acquired dyserythropoiesis. Arch Intern Med 1980; 140:554-555.
66. Molica S, Mauro FR, Giannarelli D, et al. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: On behalf ofthe GIMEMA chroniclymphoproliferative diseases working group. Haematologica 2011;96:277-283.
67. Gibson SE, Swerdlow SH, Ferry JA, et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 201 1;96:1 144-1152.
68. Rooij MF, Kuil A, Geest CR, et al. The clinically active BTK inhibitor PCI-32765 targets B-Cell receptor-and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia. Blood 2012;119: 2590-2594.
69. Ponader S, Chen SS, Buggy JJ, et al. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood 2012;119: 1182-1189.